참고문헌
- Glaspy, J.A. (2003) Hematopoietic management in oncology practice. Part 1. Myeloid growth factors. Oncology, 17, 1593-1603.
- El Ouriaghli, F., Fujiwara, H., Melenhorst, J.J., Sconocchia, G., Hensel, N. and Barrett, A.J. (2003) Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesis. Blood, 101, 1752-1758. https://doi.org/10.1182/blood-2002-06-1734
- Yong, K.L. (1996) Granulocyte colony-stimulating factor (GCSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: Comparison with granulocyte-macrophage colony-stimulating factor (GMCSF). Br. J. Haematol., 94, 40-47. https://doi.org/10.1046/j.1365-2141.1996.d01-1752.x
- Morstyn, G., Campbell, L., Souza, L.M., Alton, N.K., Keech, J., Green, M., Sheridan, W., Metcalf, D. and Fox, R. (1988) Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet, 1, 667-672.
- Price, T.H., Chatta, G.S. and Dale, D.C. (1996) Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood, 88, 335-340.
- Glaspy, J.A., Baldwin, G.C., Robertson, P.A., Souza, L., Vincent, M., Ambersley, J. and Golde, D.W. (1988) Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Ann. Intern. Med., 109, 789-795. https://doi.org/10.7326/0003-4819-109-10-789
- Yokose, N., Ogata, K., Tamura, H., An, E., Nakamura, K., Kamikubo, K., Kudoh, S., Dan, K. and Nomura, T. (1998) Pulmonary toxicity after granulocyte colonystimulating factor- combined chemotherapy for non-Hodgkin's lymphoma. Br. J. Cancer, 77, 2286-2290. https://doi.org/10.1038/bjc.1998.380
- Johnston, E., Crawford, J., Blackwell, S., Bjurstrom, T., Lockbaum, P., Roskos, L., Yang, B.B., Gardner, S., Miller-Messana, M.A., Shoemaker, D., Garst, J. and Schwab, G. (2000) Randomized, dose-escalation study of SD/ 01 compared with daily filgrastim in patients receiving chemotherapy. J. Clin. Oncol., 18, 2522-2528. https://doi.org/10.1200/JCO.2000.18.13.2522
- Inazawa, T. (2014) A case of platelet and white blood cell reduction associated with pioglitazone and fenofibrate. Diabetol. Int., 5, 202-205. https://doi.org/10.1007/s13340-014-0157-z
- Thoolen, B., Maronpot, R.R., Harada, T., Nyska, A., Rousseaux, C., Nolte, T., Malarkey, D.E., Kaufmann, W., Kuttler, K., Deschl, U., Nakae, D., Gregson, R., Vinlove, M.P., Brix, A.E., Singh, B., Belpoggi, F. and Ward, J.M. (2010) Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol. Pathol., 38, 5S-81S. https://doi.org/10.1177/0192623310386499
- Welte, K. (2014) G-CSF: filgrastim, lenograstim and biological similars. Expert Opin. Biol. Ther., 14, 983-993. https://doi.org/10.1517/14712598.2014.905537
- Akizuki, S., Mizorogi, F., Inoue, T., Sudo, K. and Ohnishi, A. (2000) Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects. Bone Marrow Transplant., 26, 939-946. https://doi.org/10.1038/sj.bmt.1702641
- Stewart, C.A. (1974) Leucocyte alkaline phosphatase in myeloid maturation. Pathology, 6, 287-293. https://doi.org/10.3109/00313027409068999
- Izumi, M., Ishikawa, J., Takeshita, A. and Maekawa, M. (2005) Increased serum alkaline phosphatase activity originating from neutrophilic leukocytes. Clin. Chem., 51, 1751-1752. https://doi.org/10.1373/clinchem.2005.052621
- Frazier, K.S., Seely, J.C., Hard, G.C., Betton, G., Burnett, R., Nakatsuji, S., Nishikawa, A., Durchfeld-Meyer, B. and Bube, A. (2012) Proliferative and nonproliferative lesions of the rat and mouse urinary system. Toxicol. Pathol., 40, 14S-86S. https://doi.org/10.1177/0192623312438736
- Kaufmann, W., Bolon, B., Bradley, A., Butt, M., Czasch, S., Garman, R.H., George, C., Gröters, S., Krinke, G., Little, P., McKay, J., Narama, I., Rao, D., Shibutani, M. and Sills, R. (2012) Proliferative and nonproliferative lesions of the rat and mouse central and peripheral systems. Toxicol. Pathol., 40, 87S-157S. https://doi.org/10.1177/0192623312439125
- Haschek, W.M., Rousseaux, C.G. and Wallig, M.A. (2010) Fundamentals of toxicologic pathology (2nd edition), Academic Press, San Diego, pp. 1-691.
- Peter, M. (2012) Background lesions in laboratory animals: a color atlas. Elsevier, New York, pp. 1-256.
- Hard, G.C. and Khan, K.N. (2004) A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment. Toxicol. Pathol., 32, 171-180. https://doi.org/10.1080/01926230490422574